Scientists have uncovered critical differences between how innate-like T cells mature in humans and mice. Early in life, most innate-like T cells in the human thymus aren't able to use all of their ...

Italian biotech Aptadir Therapeutics has launched with the promise that its pipeline of preclinical RNA inhibitors could ...

Men and women don’t experience pain the same way. Give someone an electric shock; bind a tourniquet tighter and tighter ...

Anyone with any experience as an investor knows that while penny stocks can produce strong returns, they’re also risky. You ...

Novartis has inked a deal potentially worth more than $1 billion with Flagship-founded Generate:Biomedicines to develop ...

Novo Nordisk and Eli Lilly are expected to rule the obesity market for a few more years without much challenge. To ensure they stay there as competition enters, the companies are spending billions in ...

It is our duty — to the animals and the public — to know how many animals we use and what impact such use has on patient ...

Two new therapies have successfully cleared tau aggregates in preclinical and mouse models, showing potential as dementia ...

Adolore BioTherapeutics, Inc., (”Adolore” or the “Company”), a biotechnology company developing transformational opioid-free intracellularly-delivered treatments for chronic pain, today announced that ...

In preclinical studies, a team of researchers from Mount Sinai Health System in New York City and City of Hope in Los Angeles have made significant strides in diabetes treatment. They discovered a ...

Surrozen is pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration. The milestone achievement triggers a $10 million payment to Surrozen as part ...

DELRAY BEACH, FL / ACCESSWIRE / September 24, 2024 / Adolore BioTherapeutics, Inc., ("Adolore" or the "Company"), a biotechnology company developing transformational opioid-free intracellularly-delive ...